Roberto Díez-Martínez
Directeur Général chez Ikan Biotech SL
Profil
Roberto Díez-Martínez is the founder and Chief Executive Officer of Ikan Biotech SL, a company founded in 2015.
He is currently working as the Chief Operating Officer & Director at Telum Therapeutics SL.
Postes actifs de Roberto Díez-Martínez
| Sociétés | Poste | Début |
|---|---|---|
Ikan Biotech SL
 Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Directeur Général | - |
Telum Therapeutics SL
 Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Directeur des opérations | 19/03/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Ikan Biotech SL
Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Health Technology |
Telum Therapeutics SL
Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Commercial Services |
